End-of-life pathology in UM-HET3 mice treated with 16 α‑hydroxyestradiol or late‑start canagliflozin. uri icon

authors

  • Snyder, Jessica M
  • Salmon, Adam B
  • Strong, Randy
  • Ladiges, Warren
  • Miller, Richard A
  • Harrison, David E
  • Korstanje, Ron
  • Ginsburg, Brett
  • Reifsnyder, Peter C
  • Nelson, James
  • Leiser, Scott
  • Kaczorowski, Catherine
  • Imai, Denise M

publication date

  • July 2, 2025